Trial intelligence / Profile preview

Methylphenidate (Ritalin) for severity of developmental stuttering in adults

2013-004206-26Phase 4Completed

Sponsor
Department of General Practice, Vrije Universiteit Brussel
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of methylphenidate in childhood-onset fluency disorder (COFD), sponsored by Department of General Practice, Vrije Universiteit Brussel. Primary endpoint: Severity of stuttering (primary). Started Jan 2014; status: completed.

02

Drugs

methylphenidate
03

Conditions

childhood-onset fluency disorder (COFD)

Beyond the preview

Go deeper on 2013-004206-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004206-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call